Antares Pharma (ATRS)
NASDAQ:ATRS
US Market
Holding ATRS?
Track your performance easily

Antares Pharma (ATRS) Financial Statements

0 Followers

Antares Pharma Financial Overview

Antares Pharma's market cap is currently ―. The company's EPS TTM is $0.23; its P/E ratio is 24.28; Antares Pharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Dec 21Sep 21Jun 21Mar 21
Income Statement-
Total Revenue$ 41.56M$ 48.73M$ 48.19M$ 44.98M$ 42.08M
Gross Profit$ 22.79M$ 29.76M$ 31.76M$ 28.54M$ 25.64M
EBIT$ -2.96M$ 45.87M$ 7.97M$ 6.70M$ 5.34M
EBITDA$ -2.03M$ 47.01M$ 8.92M$ 7.62M$ 6.24M
Net Income Common Stockholders$ -2.32M$ 32.68M$ 5.39M$ 6.71M$ 3.79M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 45.13M$ 52.17M$ 53.14M$ 55.65M$ 57.37M
Total Assets$ 255.66M$ 257.50M$ 216.74M$ 212.62M$ 218.46M
Total Debt$ 10.29M$ 21.90M$ 26.65M$ 29.37M$ 40.45M
Net Debt$ -34.83M$ -30.27M$ -26.48M$ -26.28M$ -16.92M
Total Liabilities$ 79.89M$ 81.75M$ 75.91M$ 80.59M$ 92.23M
Stockholders Equity$ 65.24M$ 119.11M$ 126.22M$ 132.03M$ 140.83M
Cash Flow-
Free Cash Flow$ -4.96M$ -5.98M$ 16.21M$ 5.16M$ 794.00K
Operating Cash Flow$ -4.88M$ 9.49M$ 18.72M$ 6.43M$ 1.98M
Investing Cash Flow$ 666.00K$ 1.11M$ -2.50M$ -1.27M$ -1.18M
Financing Cash Flow$ 17.00K$ -2.05M$ -3.98M$ -15.69M$ 1.72M
Currency in USD

Antares Pharma Earnings and Revenue History

Antares Pharma Debt to Assets

Antares Pharma Cash Flow

Antares Pharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis